Agreed, this stock has been really pain for all shareholders. The company has been very unloved and boring. Current news of delay in release of Cetrorelix was little disappointing. Currently, i don't own it .....I liked AEZS for many reasons except 1 and that is that current Management is great for the Company but they don't do anything to increase shareholder value...very poor in that region. However, following are few points i like about AEZS. 1)Very Undervalued: Very Low P/E ration VS. Industry average P/E= 53 and Direct competitor average P/E: 22.85. 2)Not dependent on just one product. Robust pipeline. Two marketed drugs: Cetrotide & Impavido. Multiple promising products such as cetrorelix, ozarelix and others. Cetrorelix drug is in late stage trial and looking very promising based on stage 2 results. Two other drugs(Ozarelix & Perifosine) in Phase 2 and 3 drugs in phase 1. 3) Super strong Management team for development of Company. 4) Strong balance sheet and abundant liquidity 5) Major Holder: Currently 24% of shares hold by Insiders and currently under radar of most institutional investors.

At this point, I would recommend KRY as speculative picks....recent developments indicates that long waiting permit is one the way very soon....Price could be double or more upon +ve permit news.....however, i don't see price will tumble heavily if permit delayed or didn't get one since current price justify that. My position: Yes, but very very little investment (Only 250 shares)

Reliance is another undervalued stock. lots of room for growth. As for take over target....i would rather see RS growing by itself....However, consolidation in industry will be very beneficial for RS. RS is capable of growing itself with it stock price going up at least 20% per year on average for next 3 to 4 years. Its a great long term play with substantial return. My position: Yes, I just bought some today at $50.90 and i think i will sell it once RS get around $60.

SLT is great play and hottest Indian company IPO of the year. With the smart management team, strong fundamentals and low p/e ratio definitely make this one great buy. My position: Yes, am in this ship....but i will get off once price reach around $27

I would recommend after the bad quarter they reported.....Current, sell off was more then Charter deserved. I think it is oversold and its bottom out. I suggest, get into charter and sell it once it get around $2.25. Stay away from DISH. My Position: No i don't own it at this time but i would love to if have more $$$$.